AI Summary & Key Takeaways
AI InsightIn this casepresentation, we aimed to describe the process experienced by a patient who did not manifest significant thrombocytopenia or tumoral formations in the bladder but presented with hematuria following chemotherapy, whichwas resolved with embolization, and to stress that embolization is a treatment modality that should always be keptin mind.
📌 3 Key Takeaways
Abstract
Acute myeloid leukemia patients develop thrombocytopenia due to chemotherapy and bone marrow transplantation. Thrombocytopenia-induced bleeding can be encountered at rates of 20-32% in these patients. In this casepresentation, we aimed to describe the process experienced by a patient who did not manifest significant thrombocytopenia or tumoral formations in the bladder but presented with hematuria following chemotherapy, whichwas resolved with embolization, and to stress that embolization is a treatment modality that should always be keptin mind.
Özet
Akut myeloid lösemi hastalarında kemoterapi ve kemik iliği transplantasyonuna bağlı trombositepi gelişmektedir. Trombositopeniye bağlı kanama bu hastalarda %20-32 oranında görülebilmektedir. Biz de bu vaka sunumunda belirgin trombositopeni izlenmeyen, mesanede de tümöral oluşum görülmeyen kemoterapi sonrası hematürisi olan AML hastasında, embolizasyon ile sonuçlanan süreci anlatarak, embolizasyonun her zaman akılda tutulması gerekn bir tedavi modalitesi olduğunu vurgulamak istedik.